GABAPENTIN
- Product NDC
- 61919-350
- 11-digit product format
- 619190350
- Labeler code
- 61919
- Product ID
- 61919-350_ea4e5538-f213-70bc-e053-2995a90a735a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA077662
- Marketing category
- ANDA
- Marketing start
- 2019-08-08
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-350-90 | GABAPENTIN | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-350 | GABAPENTIN TABLET GABAPENTIN CAPSULE [DIRECT RX] | 3 | Legacy NDC, 1 package rows | 20190412_2e319a08-901d-40a9-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-350-30 | 61919035030 | 30 TABLET in 1 BOTTLE (61919-350-30) | 30 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |
| 61919-350-60 | 61919035060 | 60 TABLET in 1 BOTTLE (61919-350-60) | 60 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |
| 61919-350-72 | 61919035072 | 120 TABLET in 1 BOTTLE (61919-350-72) | 120 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |
| 61919-350-90 | 61919035090 | 90 TABLET in 1 BOTTLE (61919-350-90) | 90 tablet | 2016-03-16 | 0000-00-00 | No | No | Current |